VKA Therapy Beats Switch to NOAC in Frail AF Patients : comp

Frail patients with atrial fibrillation who were switched to a newer NOAC agent had more bleeding than those left on older vitamin K antagonists, without any benefit in terms of thromboembolic events.

Related Keywords

Netherlands , Hamburg , Germany , Utrecht , Groningen , Dutch , Van Gelder , Lindapt Joosten , Isabellec Van Gelder , Renateb Schnabel , University Medical Centre Groningen , University Heart Vascular Center Hamburg , European Society Of Cardiology Congress , Julius Center , European Heart Rhythm Association , Health Sciences , International Normalized , Boehringer Ingelheim , Primary Care , European Society , Cardiology Congress , University Heart , Vascular Center Hamburg , Heart Rhythm Association , Groningen Frailty Indicator , International Normalized Ratio Guided , Atrial Fibrillation , F Atrial Fibrillation , Coumadin Therapy , Hemorrhage , Bleeding , Frailty , Frailty Syndrome , Polypharmacy , Vitamins , Anticoagulation Therapy , Anticoagulant , Anticoagulation , Thromboembolism , Europe , European , Heart , Stroke Risk , Stroke , Erebrovascular Accident , Va Cerebrovascular Accident , Arrhythmia , Clinical Guidelines , Guidelines , Hemoglobin , Emoglobin Hb , Emoglobin Hgb , Hospita ,